VIKTORIA-1 Trial of Gedatolisib Plus Fulvestrant With or Without Palbociclib in Hormone Receptor–Positive/HER2−/PIK3CA Wild-Type Advanced Breast CancerSara A. Hurvitz, Amanda Gillespie-Twardy, Giuseppe Curigliano et al.|Journal of Clinical Oncology|2026Cited by 4